China — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans — Supplements

← back to leaderboard

China received 69 FDA import refusals in Supplements, part of Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume peaked at 10 in 2025-Q4, with the trend roughly flat year-on-year. The most-cited issues are lacks firm, unapproved, and list ingre. No trade baseline is published for this commodity from China, so no per-$1B rate is shown here.

Of these, 21 were hazard refusals and 48 were paperwork refusals.

Exporting from China? Get an email when shipments from China are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

1 2023-Q4 2023-Q4: 1 6 2024-Q1 2024-Q1: 6 8 2024-Q2 2024-Q2: 8 3 2024-Q3 2024-Q3: 3 8 2024-Q4 2024-Q4: 8 6 2025-Q1 2025-Q1: 6 5 2025-Q2 2025-Q2: 5 7 2025-Q3 2025-Q3: 7 10 2025-Q4 2025-Q4: 10 4 2026-Q1 2026-Q1: 4 3 2026-Q2 2026-Q2: 3 8 2026-Q3 2026-Q3: 8

Recent rejections